News

rmdopen.bmj5d
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results ...
Background Tabalumab is a human monoclonal antibody that neutralises B-cell activating factor ... doses with at least 1 biological TNF inhibitor therapy; and stopped prior anti-TNF treatment due to ...
ascopubs.org5d
IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: A phase I dose-escalation study.
Dose escalation of KY-0118, PD-1, and IL-2v due-target fusion protein in patients with advanced renal clear cell carcinoma, urothelial carcinoma, and malignant melanoma. This is an ASCO Meeting ...